Filed: 11/14/2023ACC: 0001892688-23-000097
📋 What this filing means
DARWIN GLOBAL MANAGEMENT, LTD. filed this quarterly 13F‑HR report disclosing 3 equity positions with a total reported market value of $284.15M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
3
Positions
$284.15M
Total AUM (reported)
18.55M
Total Shares
Allocation by class
SPONSORED ADS$191.92M67.5%
COM$69.81M24.6%
SPONSORED ADR$22.43M7.9%
Portfolio Concentration
Top 3$284.15M100.0%
Top 3 weight
100.0%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 18.55M
Sole
Full voting authority
18.55M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole3
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings3
Rows:
AMBRX BIOPHARMA INC
SOLEShares16.69M
TypeSH
Market value$191.92M
67.54%
Sole
16.69M
Shared
0.00
None
0.00
IMMUNOVANT INC
SOLEShares1.82M
TypeSH
Market value$69.81M
24.57%
Sole
1.82M
Shared
0.00
None
0.00
ARGENX SE
SOLEShares45.62K
TypeSH
Market value$22.43M
7.89%
Sole
45.62K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
AMBRX BIOPHARMA INCSOLE | SPONSORED ADS | 16.69M | SH | $191.92M 67.54% | 16.69M | 0.00 | 0.00 |
IMMUNOVANT INCSOLE | COM | 1.82M | SH | $69.81M 24.57% | 1.82M | 0.00 | 0.00 |
ARGENX SESOLE | SPONSORED ADR | 45.62K | SH | $22.43M 7.89% | 45.62K | 0.00 | 0.00 |